Diffuse idiopathic skeletal hyperostosis: a review

Beyond Rheumatology 2021; 2 (3): e282
DOI: 10.4081/br.2020.52

  Topic: Metabolic syndrome     Category:

Abstract

Coined in 1975 by Resnick ., diffuse idiopathic skeletal hyperostosis describes a systemic condition that is mainly characterized by flowing ossification of the spine and, less frequently, peripheral entheses. Its overall incidence is 6-12%, but it is more frequently observed in males than in females and subjects aged >50 years, and its increased prevalence in people aged >70 years suggests that the course of the disease begins between the third and fifth decade of life but its clinical manifestations do not appear until later. Its pathogenesis and etiology remain unknown, but it has been reported to be associated with a number of genetic, metabolic, and constitutional factors.

The aim of this review is to describe the main features of the disease and stimulate research into its pathogenesis, prevention, and treatment.

To cite this article

Diffuse idiopathic skeletal hyperostosis: a review

Beyond Rheumatology 2021; 2 (3): e282
DOI: 10.4081/br.2020.52

Publication History

Published online: 11 Jan 2021